Solid Biosciences, Inc. (SLDB)
10.10
+0.38
(+3.91%)
USD |
NASDAQ |
Aug 27, 14:42
Solid Biosciences Total Assets (Quarterly) : 420.58M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 420.58M |
| March 31, 2026 | 422.89M |
| December 31, 2025 | 232.54M |
| September 30, 2025 | 273.91M |
| June 30, 2025 | 308.29M |
| March 31, 2025 | 343.90M |
| December 31, 2024 | 188.66M |
| September 30, 2024 | 211.83M |
| June 30, 2024 | 230.98M |
| March 31, 2024 | 248.69M |
| December 31, 2023 | 164.94M |
| September 30, 2023 | 184.73M |
| June 30, 2023 | 204.72M |
| March 31, 2023 | 229.59M |
| December 31, 2022 | 260.25M |
| September 30, 2022 | 184.47M |
| June 30, 2022 | 208.50M |
| March 31, 2022 | 207.56M |
| December 31, 2021 | 232.38M |
| September 30, 2021 | 248.99M |
| Date | Value |
|---|---|
| June 30, 2021 | 265.86M |
| March 31, 2021 | 285.28M |
| December 31, 2020 | 171.17M |
| September 30, 2020 | 40.52M |
| June 30, 2020 | 57.96M |
| March 31, 2020 | 73.96M |
| December 31, 2019 | 103.47M |
| September 30, 2019 | 130.93M |
| June 30, 2019 | 96.30M |
| March 31, 2019 | 120.23M |
| December 31, 2018 | 139.60M |
| September 30, 2018 | 156.81M |
| June 30, 2018 | 171.47M |
| March 31, 2018 | 189.24M |
| December 31, 2017 | 76.19M |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 55.03M |
| December 31, 2016 | 40.64M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.50M |
| Shareholders Equity (Quarterly) | 374.08M |
| Debt to Equity Ratio | 0.0539 |
| Current Ratio | 13.82 |
| Net Debt Paydown Yield | 0.07% |